Table 3.
Parameters | Control | ADAE | STZ | ADAE + STZ |
---|---|---|---|---|
TBARS (nmol/g tissue) | 21.67 ± 0.78c | 16.96 ± 0.63d | 30.71 ± 1.08a | 25.35 ± 0.78b |
H2O2 (µmol/g tissue) | 30.41 ± 0.98c | 24.36 ± 0.72d | 42.84 ± 1.63a | 35.07 ± 1.27b |
GSH (mmol/mg protein) | 15.54 ± 0.61b | 18.32 ± 0.64a | 8.43 ± 0.24d | 11.34 ± 0.38c |
SOD (U/mg protein) | 4.14 ± 0.149b | 5.02 ± 0.184a | 2.28 ± 0.075d | 3.38 ± 0.111c |
CAT (μmol/h/mg protein) | 46 ± 1.65b | 54 ± 1.03a | 26 ± 0.86d | 37 ± 1.08c |
GST (µmol/hr/mg protein) | 0.77 ± 0.028b | 0.93 ± 0.034a | 0.41 ± 0.016d | 0.61 ± 0.022c |
GPx (U/mg protein) | 0.785 ± 0.034b | 0.931 ± 0.031a | 0.440 ± 0.010d | 0.610 ± 0.030c |
GR (U/mg protein) | 0.876 ± 0.034b | 1.033 ± 0.035a | 0.531 ± 0.019d | 0.722 ± 0.028c |
Values are expressed as means ± SE (n = 6) for each treatment group. a, b, cMean values within a row not sharing a common superscript letter were significantly different, p < 0.05. Statistically significant variations are compared as follows: the ADAE and STZ groups compared with the control group and the ADAE + STZ group compared with the STZ group.